Egalet has built a robust pipeline built around products developed using its Guardian Technology. The Company licensed and acquired two approved products, OXAYDO and SPRIX Nasal Spray respectively, which are marketed to the same healthcare providers that will ultimately prescribe the Guardian Technology products.
AD = abuse-deterrent; ER = extended release.
*Management of pain severe enough to require around-the-clock opioid treatment and for which alternative treatments are inadequate.
OXAYDO is a registered trademark of Egalet Corporation.
SPRIX is a registered trademark of Egalet Corporation.
ARYMO is a trademark of Egalet Corporation.
SPRIX is a registered trademark of Egalet Corporation.
ARYMO is a trademark of Egalet Corporation.